The genomics of response to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer - results from the ACOSOG Z1041 (Alliance) trial


- Citation:
- Meeting Instance:
- PCC 2016
- Year:
- 2016
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Note:
- http://pccradiumhospital.org/content/text_8ef111f1-5736-4092-8487-6601340066bb/1456755424010/pcc2016_a5.pdf
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 2611